• Thumbnail for Incyte
    Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company...
    11 KB (763 words) - 16:06, 3 June 2024
  • Thumbnail for Ruxolitinib
    Ruxolitinib is a Janus kinase inhibitor. It was developed and marketed by Incyte Corp in the US under the brand name Jakafi, and by Novartis elsewhere in...
    26 KB (2,102 words) - 02:19, 16 July 2024
  • Thumbnail for Nasdaq-100
    Altera was removed on October 7 as a result of its merger with Intel. Incyte replaced Altera's on that date. PayPal was added to the index on November...
    59 KB (5,031 words) - 23:53, 30 August 2024
  • treatment of Merkel cell carcinoma. The applicant for this medicinal product is Incyte Biosciences Distribution B.V. Retifanlimab is the international nonproprietary...
    9 KB (460 words) - 01:46, 18 May 2024
  • Thumbnail for Epacadostat
    being investigated by Incyte and Merck & Co. in several cancers, as was the combination of epacadostat with nivolumab (Opdivo) by Incyte and Bristol Myers...
    6 KB (321 words) - 23:06, 13 February 2024
  • Thumbnail for PD-1 and PD-L1 inhibitors
    recurrent or advanced solid tumors. Retifanlimab (Zynyz) was developed by Incyte and first granted accelerated approval by the FDA in March 2023 for the...
    31 KB (3,266 words) - 05:29, 20 May 2024
  • T90 Tracer 2011–2012: Nike Seitiro 2012–2013: Nike Maxim 2013–2014: Nike Incyte 2014–2015: Nike Ordem 2 2015–2016: Nike Ordem 3 2016–2017: Nike Ordem 4...
    44 KB (2,625 words) - 21:47, 26 August 2024
  • years, Nike provided the official ball for all matches, with a new Nike Incyte Liga BBVA model being used throughout the season for all matches. Notes...
    64 KB (2,643 words) - 06:42, 29 August 2024
  • Thumbnail for Dermatitis
    "Incyte Announces U.S. FDA Approval of Opzelura (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)". Incyte. 21...
    68 KB (6,964 words) - 22:47, 26 August 2024
  • Thumbnail for Baricitinib
    eliminated via the urine, and 20% via the faeces. Baricitinib was discovered by Incyte and licensed to Eli Lilly. In January 2016, Eli Lilly submitted a new drug...
    43 KB (3,613 words) - 02:13, 16 July 2024